Aberrant resting-state functional connectivity of salience network in first-episode schizophrenia.

First-episode schizophrenia Functional connectivity Resting-state functional magnetic resonance imaging Salience network

Journal

Brain imaging and behavior
ISSN: 1931-7565
Titre abrégé: Brain Imaging Behav
Pays: United States
ID NLM: 101300405

Informations de publication

Date de publication:
Oct 2020
Historique:
pubmed: 29 1 2019
medline: 28 4 2021
entrez: 29 1 2019
Statut: ppublish

Résumé

The disruption of salience network (SN) has been consistently found in patients with schizophrenia and thought to give rise to specific symptoms. However, the functional dysconnectivity pattern of SN remains unclear in first-episode schizophrenia (FES). Sixty-five patients with FES and sixty-six health controls (HC) were enrolled in this study and underwent resting-state functional magnetic resonance imaging (rs-fMRI). The eleven regions of interest (ROIs) within SN were derived from the peaks of the group independent component analysis (gICA). Seed-based whole-brain functional connectivity (FC) analyses were performed with all SN ROIs as the seeds. Both hyper- and hypo-connectivity of SN were found in the FES. Specifically, the increased FC mainly existed between the SN and cortico-cerebellar sub-circuit and prefrontal cortex, while the reduced FC mainly existed within cortico-striatal-thalamic-cortical (CSTC) sub-circuit. Our findings suggest that FES is associated with pronounced dysregulation of SN, characterized prominently by hyperconnectivity of SN-prefrontal cortex and cerebellum, as well as hypoconnectivity of CSTC sub-circuit of the SN.

Identifiants

pubmed: 30689171
doi: 10.1007/s11682-019-00040-8
pii: 10.1007/s11682-019-00040-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1350-1360

Subventions

Organisme : SHSMU- ION Research Center for Brain Disorders
ID : 2015NKX001, 15ZH2015, W35XT
Organisme : Medicine Engineering Intersection Program of Shanghai Jiaotong University
ID : YG2015ZD12
Organisme : Shanghai Hospital Development Center
ID : 16CR2015A, 16CR3017A
Organisme : Projects of medical and health development in Shandong province
ID : 2017WS115
Organisme : Shanghai Jiao Tong University Foundation
ID : YG2014MS40
Organisme : NIMH NIH HHS
ID : R01 MH084900
Pays : United States
Organisme : Shanghai Science and Technology Committee
ID : 17ZR1424700
Organisme : Projects of medical and health development in Qingdao city
ID : 2016WJZD068
Organisme : National Key Clinical Disciplines at Shanghai Mental Health Center
ID : OMA-MH, 2011-873
Organisme : Shanghai Key Laboratory of Psychotic Disorders
ID : 13dz2260500
Organisme : Ministry of Science and Technology of China
ID : 2016YFC1306803
Organisme : Doctoral Innovation Fund from Shanghai Jiaotong University School of Medicine
ID : BXJ201639
Organisme : National Natural Science Foundation of China
ID : 81671329
Organisme : Program of Shanghai Academic/Technology Research Leader
ID : 16XD1402400
Organisme : National Natural Science Foundation of China
ID : 81671332
Organisme : Shanghai Science and Technology Committee
ID : 16JC1420200
Organisme : Shanghai Jiao Tong University Foundation
ID : 14JCRY04

Auteurs

Huan Huang (H)

Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, 430060, China.
Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Zeng Botao (Z)

Department of Psychiatry, Qingdao Mental Health Center, Qingdao, China.

Yuchao Jiang (Y)

Key Laboratory for NeuroInformation of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, China.

Yingying Tang (Y)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Tianhong Zhang (T)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Xiaochen Tang (X)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Lihua Xu (L)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Junjie Wang (J)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Jin Li (J)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Zhenying Qian (Z)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Xu Liu (X)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.

Huiling Wang (H)

Department of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

Cheng Luo (C)

Key Laboratory for NeuroInformation of Ministry of Education, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, 610054, China.

Chunbo Li (C)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China.
CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Science, Beijing, China.
Brain Science and Technology Research Center, Shanghai Jiao Tong University, Shanghai, 200030, China.

Jian Xu (J)

Department of Neurology, Nantong University Affiliated Mental Health Center, Nantong, 226005, Jiangsu, China. xujianr@163.com.

Donald Goff (D)

Department of Psychiatry, New York University Langone Medical Center, One Park Ave, Room 8-212, New York, NY, 10116, USA.

Jijun Wang (J)

Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Shanghai, 200030, China. jijunwang27@163.com.
CAS Center for Excellence in Brain Science and Intelligence Technology (CEBSIT), Chinese Academy of Science, Beijing, China. jijunwang27@163.com.
Brain Science and Technology Research Center, Shanghai Jiao Tong University, Shanghai, 200030, China. jijunwang27@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH